# NIH TETRAMER CORE FACILITY FOR INFECTIOUS DISEASES

> **NIH NIH N01** · EMORY UNIVERSITY · 2024 · $500,000

## Abstract

The National Institute of Allergy and Infectious Diseases (NIAID) supports research on the basic understanding of immune responses leading to the development of vaccines and novel therapeutic agents for the prevention and treatment of infectious and immune-mediated diseases, and improvements in public health. This research includes support of various reagent facilities, repositories, and databases that provide resources for biomedical researchers. NIAID supports the MHC Tetramer Core facility which provides synthesis and distribution of soluble MHC tetramer reagents to the global research community.

## Key facts

- **NIH application ID:** 11060158
- **Project number:** 75N93020D00005-P00005-759302000001-2
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** JOHN ALTMAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $500,000
- **Award type:** —
- **Project period:** 2020-03-21 → 2027-03-20

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11060158

## Citation

> US National Institutes of Health, RePORTER application 11060158, NIH TETRAMER CORE FACILITY FOR INFECTIOUS DISEASES (75N93020D00005-P00005-759302000001-2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11060158. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*